These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 31114804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing.
    Johnson CT, Wroe JA, Agarwal R, Martin KE, Guldberg RE, Donlan RM, Westblade LF, García AJ.
    Proc Natl Acad Sci U S A; 2018 May 29; 115(22):E4960-E4969. PubMed ID: 29760099
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model.
    Windolf CD, Lögters T, Scholz M, Windolf J, Flohé S.
    PLoS One; 2014 May 29; 9(12):e115940. PubMed ID: 25536060
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lysostaphin: an antistaphylococcal agent.
    Kumar JK.
    Appl Microbiol Biotechnol; 2008 Sep 29; 80(4):555-61. PubMed ID: 18607587
    [Abstract] [Full Text] [Related]

  • 7. Dual-Functional Implant Based on Gellan-Xanthan Hydrogel with Diopside, BMP-2 and Lysostaphin for Bone Defect Repair and Control of Staphylococcal Infection.
    Karyagina AS, Grishin AV, Kudinova AG, Bulygina IN, Koudan EV, Orlova PA, Datsenko VP, Zhulina AV, Grunina TM, Poponova MS, Krivozubov MS, Gromova MS, Strukova NV, Generalova MS, Nikitin KE, Shchetinin IV, Luchnikov LO, Zaitseva SV, Kirsanova MA, Statnik ES, Senatov FS, Lunin VG, Gromov AV.
    Macromol Biosci; 2024 Nov 29; 24(11):e2400205. PubMed ID: 39140453
    [Abstract] [Full Text] [Related]

  • 8. [Topical use of lysostaphin for Staphylococcus aureus infection of burn wounds in mice].
    Huan JN.
    Zhonghua Wai Ke Za Zhi; 1992 May 29; 30(5):270-1, 316. PubMed ID: 1289000
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections.
    Landa G, Aguerri L, Irusta S, Mendoza G, Arruebo M.
    Int J Biol Macromol; 2024 Jun 29; 271(Pt 1):132563. PubMed ID: 38782313
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream.
    Cui F, Li G, Huang J, Zhang J, Lu M, Lu W, Huang Q.
    Drug Deliv; 2010 Nov 29; 17(8):617-23. PubMed ID: 20726810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapeutic applications of lysostaphin against Staphylococcus aureus.
    Jayakumar J, Kumar VA, Biswas L, Biswas R.
    J Appl Microbiol; 2021 Sep 29; 131(3):1072-1082. PubMed ID: 33382154
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of a lysostaphin-fusion protein as a dry-cow therapy for Staphylococcus aureus mastitis in dairy cattle.
    Hoernig KJ, Donovan DM, Pithua P, Williams F, Middleton JR.
    J Dairy Sci; 2016 Jun 29; 99(6):4638-4646. PubMed ID: 27040789
    [Abstract] [Full Text] [Related]

  • 20. Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit.
    Dajcs JJ, Thibodeaux BA, Hume EB, Zheng X, Sloop GD, O'Callaghan RJ.
    Curr Eye Res; 2001 Jun 29; 22(6):451-7. PubMed ID: 11584345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.